Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

  • Zabana, Yamile
  • Marín-Jiménez, Ignacio
  • Rodríguez-Lago, Iago
  • Vera, Isabel
  • Martín-Arranz, María Dolores
  • Guerra, Iván
  • Gisbert, Javier P.
  • Mesonero, Francisco
  • Benítez, Olga
  • Taxonera, Carlos
  • Ponferrada-Díaz, Ángel
  • Piqueras, Marta
  • Lucendo, Alfredo J.
  • Caballol, Berta
  • Mañosa, Míriam
  • Martínez-Montiel, Pilar
  • Bosca-Watts, Maia
  • Gordillo, Jordi
  • Bujanda, Luis
  • Manceñido, Noemí
  • Martínez-Pérez, Teresa
  • López, Alicia
  • Rodríguez-Gutiérrez, Cristina
  • García-López, Santiago
  • Vega, Pablo
  • Rivero, Montserrat
  • Melcarne, Luigi
  • Calvo, Maria
  • Iborra, Marisa
  • Barreiro de-Acosta, Manuel
  • Sicilia, Beatriz
  • Barrio, Jesús
  • Pérez, José Lázaro
  • Busquets, David
  • Pérez-Martínez, Isabel
  • Navarro-Llavat, Mercè
  • Hernández, Vicent
  • Argüelles-Arias, Federico
  • Ramírez Esteso, Fernando
  • Meijide, Susana
  • Ramos, Laura
  • Gomollón, Fernando
  • Muñoz, Fernando
  • Suris, Gerard
  • de Zarate, Jone Ortiz
  • Huguet, José María
  • Llaó, Jordina
  • García-Sepulcre, Mariana Fe
  • Sierra, Mónica
  • Durà, Miguel
  • Estrecha, Sandra
  • Fuentes Coronel, Ana
  • Hinojosa, Esther
  • Olivan, Lorenzo
  • Iglesias, Eva
  • Gutiérrez, Ana
  • Varela, Pilar
  • Rull, Núria
  • Gilabert, Pau
  • Hernández-Camba, Alejandro
  • Brotons, Alicia
  • Ginard, Daniel
  • Sesé, Eva
  • Carpio, Daniel
  • Aceituno, Montserrat
  • Cabriada, José Luis
  • González-Lama, Yago
  • Jiménez, Laura
  • Chaparro, María
  • López-San Román, Antonio
  • Alba, Cristina
  • Plaza-Santos, Rocío
  • Mena, Raquel
  • Tamarit-Sebastián, Sonsoles
  • Ricart, Elena
  • Calafat, Margalida
  • Olivares, Sonsoles
  • Navarro, Pablo
  • Bertoletti, Federico
  • Alonso-Galán, Horacio
  • Pajares, Ramón
  • Olcina, Pablo
  • Manzano, Pamela
  • Domènech, Eugeni
  • Esteve, Maria
We aim to describe the incidence and source of contagion of COVID-19 in patients with IBD, as well as the risk factors for a severe course and long-term sequelae. This is a prospective observational study of IBD and COVID-19 included in the ENEIDA registry (53,682 from 73 centres) between March–July 2020 followed-up for 12 months. Results were compared with data of the general population (National Centre of Epidemiology and Catalonia). A total of 482 patients with COVID-19 were identified. Twenty-eight percent were infected in the work environment, and 48% were infected by intrafamilial transmission, despite having good adherence to lockdown. Thirty-five percent required hospitalization, 7.9% had severe COVID-19 and 3.7% died. Similar data were reported in the general population (hospitalisation 19.5%, ICU 2.1% and mortality 4.6%). Factors related to death and severe COVID-19 were being aged ≥ 60 years (OR 7.1, 95% CI: 1.8–27 and 4.5, 95% CI: 1.3–15.9), while having ≥2 comorbidities increased mortality (OR 3.9, 95% CI: 1.3–11.6). None of the drugs for IBD were related to severe COVID-19. Immunosuppression was definitively stopped in 1% of patients at 12 months. The prognosis of COVID-19 in IBD, even in immunosuppressed patients, is similar to that in the general population. Thus, there is no need for more strict protection measures in IBD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Nationwide COVID-19-EII Study, Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

  • Zabana, Yamile|||0000-0003-4023-8868
  • Marín Jiménez, Ignacio|||0000-0001-5424-2484
  • Rodríguez-Lago, Iago|||0000-0003-1133-4578
  • Vera-Mendoza, Isabel
  • Martín-Arranz, María Dolores|||0000-0002-1872-0917
  • Guerra, Iván|||0000-0002-5175-2515
  • P. Gisbert, Javier|||0000-0003-2090-3445
  • Mesonero, Francisco|||0000-0002-7864-8187
  • Benítez-Leiva, Olga|||0000-0003-1748-7751
  • Taxonera, Carlos|||0000-0001-9166-7350
  • Ponferrada Díaz, Ángel|||0000-0002-1176-276X
  • Piqueras, Marta|||0000-0002-3874-2638
  • Lucendo, Alfredo J.|||0000-0003-1183-1072
  • Caballol, Berta|||0000-0002-7921-6730
  • Mañosa i Ciria, Míriam|||0000-0002-9051-2581
  • Martínez Montiel, Pilar|||0000-0002-8688-8244
  • Bosca-Watts, Marta Maia|||0000-0001-7495-8797
  • Gordillo, Jordi|||0000-0001-6418-0715
  • Bujanda, Luis|||0000-0002-4353-9968
  • Manceñido, Noemí|||0000-0002-8089-9858
  • Martínez-Pérez, Teresa
  • López, Alicia
  • Rodríguez Gutiérrez, Cristina|||0000-0003-3954-0736
  • García-López, Santiago|||0000-0003-3970-5457
  • Vega Villaamil, Pablo|||0000-0001-7545-6297
  • Rivero, Montserrat|||0000-0002-5834-1559
  • Melcarne, Luigi|||0000-0002-9718-9692
  • Calvo Iñiguez, María|||0000-0002-9862-2427
  • Iborra, Marisa|||0000-0001-7360-7581
  • Barreiro de-Acosta, Manuel|||0000-0001-5915-1477
  • Sicilia Aladrén, Beatriz|||0000-0002-4495-9358
  • Barrio, Jesús|||0000-0001-7087-3921
  • Pérez-Calle, José Lázaro|||0000-0002-8724-2760
  • Busquets, David|||0000-0002-9385-1415
  • Pérez-Martínez, Isabel|||0000-0002-2535-1929
  • Navarro-Llavat, Mercè|||0000-0002-1132-0427
  • Hernández, Vicent|||0000-0003-1607-0831
  • Argüelles-Arias, Federico|||0000-0003-3646-8919
  • Ramírez Esteso, Fernando|||0000-0003-4728-5253
  • Meijide, Susana
  • Ramos López, Laura|||0000-0001-7015-1742
  • Gomollón, Fernando|||0000-0003-0076-3529
  • Muñoz, Fernando
  • Suris, Gerard
  • de Zarate, Jone Ortiz
  • Huguet, José María|||0000-0001-6486-1262
  • Llaó, Jordina
  • García-Sepulcre, Mariana Fe|||0000-0002-1329-9529
  • Sierra Ausín, Mónica|||0000-0003-3342-8209
  • Durà, Miguel
  • Estrecha, Sandra
  • Fuentes Coronel, Ana María|||0000-0001-8862-0922
  • Hinojosa, Esther
  • Olivan, Lorenzo|||0000-0002-7215-6907
  • Iglesias-Flores, Eva
  • Gutiérrez Casbas, Ana|||0000-0002-5460-4139
  • Varela, Pilar|||0000-0003-1737-3236
  • Rull, Núria
  • Gilabert, Pau
  • Hernández Camba, Alejandro|||0000-0002-8653-207X
  • Brotons, Alicia|||0000-0003-3017-1671
  • Ginard, Daniel
  • Sesé Abizanda, Eva
  • Carpio, Daniel|||0000-0001-7929-1151
  • Aceituno, Montserrat|||0000-0003-0352-9527
  • Cabriada, José Luis|||0000-0002-3068-5659
  • González-Lama, Yago|||0000-0003-3896-7914
  • Jiménez, Laura
  • Chaparro, María|||0000-0002-9275-4242
  • López San Román, Antonio|||0000-0003-0236-4118
  • Alba, Cristina
  • Plaza-Santos, Rocío|||0000-0003-0893-4599
  • Mena, Raquel
  • Tamarit-Sebastián, Sonsoles|||0000-0001-5309-8310
  • Ricart, Elena
  • Calafat, Margalida|||0000-0003-2335-3792
  • Olivares, Sonsoles
  • Navarro, Pablo|||0000-0001-6228-3462
  • Bertoletti, Federico|||0000-0002-1484-3952
  • Alonso-Galán, Horacio
  • Pajares, Ramón|||0000-0003-0549-6036
  • Olcina, Pablo|||0000-0001-8898-0231
  • Manzano, Pamela
  • Domènech, Eugeni|||0000-0002-2315-7196
  • Esteve, Maria|||0000-0001-7716-0027
We aim to describe the incidence and source of contagion of COVID-19 in patients with IBD, as well as the risk factors for a severe course and long-term sequelae. This is a prospective observational study of IBD and COVID-19 included in the ENEIDA registry (53,682 from 73 centres) between March-July 2020 followed-up for 12 months. Results were compared with data of the general population (National Centre of Epidemiology and Catalonia). A total of 482 patients with COVID-19 were identified. Twenty-eight percent were infected in the work environment, and 48% were infected by intrafamilial transmission, despite having good adherence to lockdown. Thirty-five percent required hospitalization, 7.9% had severe COVID-19 and 3.7% died. Similar data were reported in the general population (hospitalisation 19.5%, ICU 2.1% and mortality 4.6%). Factors related to death and severe COVID-19 were being aged ≥ 60 years (OR 7.1, 95% CI: 1.8-27 and 4.5, 95% CI: 1.3-15.9), while having ≥2 comorbidities increased mortality (OR 3.9, 95% CI: 1.3-11.6). None of the drugs for IBD were related to severe COVID-19. Immunosuppression was definitively stopped in 1% of patients at 12 months. The prognosis of COVID-19 in IBD, even in immunosuppressed patients, is similar to that in the general population. Thus, there is no need for more strict protection measures in IBD.